FDA News for Type 2 Diabetes Treatments: Jentadueto XR & IDegLira
- Eli Lilly and Company. U.S. FDA Approves Once-daily Jentadueto XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes. PR Newswire. Published May 31, 2016 Accessed June 1, 2016.
- Tucker M. FDA OKs Linagliptin/Metformin Combo for Type 2 Diabetes. Medscape. Published May 31, 2016 Accessed June 1, 2016.
- Barber J. FDA advisory panel unanimously backs approval of Novo Nordisk's diabetes drug IDegLira. FirstWord Pharma. Published May 24, 2016. Accessed June 1, 2016.
- Ault A. FDA Panel Backs Novo Nordisk Insulin–GLP-1 Combination IDegLira. Medscape. Published May 25, 2016. Accessed June 1, 2016.